
Intermittent Explosive Disorder (IED): A Comprehensive Guide
Core Definition
Intermittent Explosive Disorder is an impulse-control disorder characterized by:
- Recurrent, sudden episodes of verbal aggression or physical violence
- Outbursts grossly disproportionate to provocation/stress
- Not premeditated (distinguishes from Conduct Disorder)
- Causes marked distress or functional impairment
DSM-5 Diagnostic Criteria
Required:
A. Recurrent behavioral outbursts representing failure to control aggressive impulses, manifested as either:
- Verbal aggression (tantrums, tirades) or physical aggression toward property/animals/others, occurring ≥2× weekly for 3 months (doesn’t cause damage/injury)
OR - Physical assault causing injury/destruction, occurring ≥3× in 12 months
B. Outbursts are not better explained by another mental disorder, substance use, or medical condition
Clinical Presentation
Typical Outburst Pattern:
- Trigger: Minor frustration (e.g., traffic jam, criticism)
- Escalation: Rapid progression from irritation to rage (<5 mins)
- Explosion: Aggressive behavior (screaming, hitting, throwing objects)
- Resolution: Regret/embarrassment after exhaustion (not guilt)
Key Features:
- Brief duration (usually <30 minutes)
- Targets familiar people (family > strangers)
- No “cooling off” once triggered
- May report physical sensations (tunnel vision, pounding heart)
Between Episodes:
- Often describe themselves as “short-fused”
- May exhibit chronic irritability
- Typically no antisocial traits (vs. Conduct Disorder)
Neurobiology & Risk Factors
Biological Underpinnings:
- Low serotonin in orbitofrontal cortex (impulse control)
- Amygdala hyperactivity (threat detection)
- Reduced prefrontal inhibition (poor emotional regulation)
Risk Factors:
- Childhood: Physical/verbal abuse, inconsistent discipline
- Temperament: High emotional reactivity
- Comorbidities: ADHD (40%), mood/anxiety disorders (35%)
- Substances: Alcohol exacerbates outbursts
Evidence-Based Treatments
1. Pharmacotherapy
- SSRIs (First-line): Fluoxetine (60% respond at 60mg/day)
- Mood Stabilizers: Lithium (for severe aggression)
- Anticonvulsants: Carbamazepine, valproate
- Beta-blockers: Propranolol (for autonomic hyperactivity)
2. Psychotherapy
- Cognitive Behavioral Therapy (CBT):
- Identifies escalation cues (physical/emotional)
- Teaches time-out techniques
- Challenges catastrophic thinking (“This is unbearable!”)
- Mindfulness-Based Stress Reduction (MBSR): Improves distress tolerance
3. Emergency Management
- Benzodiazepines (short-term): For acute agitation (risk of disinhibition)
- Physical restraints: Only if imminent danger (increases trauma risk)
Differential Diagnosis
| Condition | Distinguishing Features |
|---|---|
| Borderline PD | Aggression tied to abandonment fears |
| Bipolar Disorder | Episodic mood elevation/irritability |
| Conduct Disorder | Goal-directed aggression, lacks remorse |
| Dementia | Aggression from cognitive impairment |
Prognosis & Management
Course:
- Mean onset: Late adolescence
- Chronic but treatable (50% reduction in outbursts with CBT+meds)
- Triggers persist but reactions become manageable
Daily Strategies:
- Sleep hygiene (fatigue lowers threshold)
- Avoid stimulants (caffeine, nicotine)
- Exercise regimen (regulates serotonin)
- “Cool-down” protocol (pre-identified safe space)
When to Hospitalize
- Homicidal ideation/intent
- Self-injurious behavior during outbursts
- Complete loss of behavioral control
Red Flag: Episodes lasting >1 hour suggest alternate diagnosis (e.g., bipolar mixed episode)
